Guide to Diagnostic Tests
Sinusitis
To view the entire topic, please log in or purchase a subscription.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
Organism
Sinusitis
Acute: S. pneumoniae (GPDC) (20–43%), H. influenzae (GNCB) (21–35%), M. catarrhalis (GNDC) (2–10%), other streptococci (3–9%) (GPC), anaerobes (1–9%), viruses (4%) (adenovirus, influenza, parainfluenza), S. aureus (GPC) (1–8%).
Chronic (child): Viridans and anaerobic streptococci (GPC in chains) (23%), S. aureus (19%), S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa (GNR) in cystic fibrosis.
Chronic (adult): Coagulase-negative staphylococci (GPC) (36%), S. aureus (GPC) (25%), viridans streptococci (GPC in chains) (8%), corynebacteria (GPR) (5%), anaerobes (6%), including Bacteroides sp., Prevotella sp. (GNR), peptostreptococcus (GPC), Fusobacterium sp. (GNR).
Hospitalized with nasogastric tube or nasotracheal intubation: Enterobacteriaceae (GNR), Pseudomonas sp. (GNR).
Fungal: Zygomycetes (rhizopus), aspergillus, P. boydii , other dematiaceous mold.
Immunocompromised: P. aeruginosa (GNR), CMV, Aspergillus sp. and other filamentous fungi plus microsporidia, Cryptosporidium parvum, Acanthamoeba in HIV-infected patients.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Organism
Sinusitis
Acute: S. pneumoniae (GPDC) (20–43%), H. influenzae (GNCB) (21–35%), M. catarrhalis (GNDC) (2–10%), other streptococci (3–9%) (GPC), anaerobes (1–9%), viruses (4%) (adenovirus, influenza, parainfluenza), S. aureus (GPC) (1–8%).
Chronic (child): Viridans and anaerobic streptococci (GPC in chains) (23%), S. aureus (19%), S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa (GNR) in cystic fibrosis.
Chronic (adult): Coagulase-negative staphylococci (GPC) (36%), S. aureus (GPC) (25%), viridans streptococci (GPC in chains) (8%), corynebacteria (GPR) (5%), anaerobes (6%), including Bacteroides sp., Prevotella sp. (GNR), peptostreptococcus (GPC), Fusobacterium sp. (GNR).
Hospitalized with nasogastric tube or nasotracheal intubation: Enterobacteriaceae (GNR), Pseudomonas sp. (GNR).
Fungal: Zygomycetes (rhizopus), aspergillus, P. boydii , other dematiaceous mold.
Immunocompromised: P. aeruginosa (GNR), CMV, Aspergillus sp. and other filamentous fungi plus microsporidia, Cryptosporidium parvum, Acanthamoeba in HIV-infected patients.
There's more to see -- the rest of this topic is available only to subscribers.
